TINA CARR: Open Payments
NPI 1144089038 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$259 in 12 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $277 · 2025 $259
Food & beverage: $259
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $153 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $51 |
| Regeneron Healthcare Solutions, Inc. | 1 | $32 |
| Janssen Biotech, Inc. | 1 | $22 |
Products named: MAVYRET, ENTYVIO, DUPIXENT, TREMFYA, LINZESS, RINVOQ.
Industry payments across AZ — which companies pay providers there.
